Back to top
more

HCA Healthcare (HCA)

(Delayed Data from NYSE)

$306.69 USD

306.69
2,257,040

-7.43 (-2.37%)

Updated Apr 26, 2024 04:00 PM ET

After-Market: $306.50 -0.19 (-0.06%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth B Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 4% (10 out of 252)

Industry: Medical - Hospital

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Brokerage Reports

Research for HCA

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

0 items in cart

HCA Healthcare, Inc. [HCA]

Reports for Purchase

Showing records 241 - 260 ( 280 total )

Company: HCA Healthcare, Inc.

Industry: Medical - Hospital

Record: 241

05/05/2015

Company Report

Pages: 9

Raising Estimates Following Strong 1Q

Provider: KEYBANC CAPITAL MARKETS

Analyst: GURDA J

Price: 25.00

Research Provided by a Third Party

Company: HCA Healthcare, Inc.

Industry: Medical - Hospital

Record: 242

04/15/2015

Daily Note

Pages: 3

Pre-Announces Higher than Expected 1Q Results

Provider: KEYBANC CAPITAL MARKETS

Analyst: GURDA J

Price: 10.00

Research Provided by a Third Party

Company: HCA Healthcare, Inc.

Industry: Medical - Hospital

Record: 243

02/03/2015

Daily Note

Pages: 3

Guides 2015 Below Street; 4Q Looks a Little Better

Provider: KEYBANC CAPITAL MARKETS

Analyst: GURDA J

Price: 10.00

Research Provided by a Third Party

Company: HCA Healthcare, Inc.

Industry: Medical - Hospital

Record: 244

02/03/2015

Company Report

Pages: 8

Upside Opportunity Offset by Valuation, SCOTUS Risk

Provider: KEYBANC CAPITAL MARKETS

Analyst: GURDA J

Price: 25.00

Research Provided by a Third Party

Company: HCA Healthcare, Inc.

Industry: Medical - Hospital

Record: 245

01/11/2015

Company Report

Pages: 5

4Q Admissions Growth Accelerates, but EBITDA Is Mixed

Provider: KEYBANC CAPITAL MARKETS

Analyst: GURDA J

Price: 10.00

Research Provided by a Third Party

Company: HCA Healthcare, Inc.

Industry: Medical - Hospital

Record: 246

10/28/2014

Company Report

Pages: 9

The Strong Rebound in Volumes, How Long Will It Continue?

Provider: KEYBANC CAPITAL MARKETS

Analyst: GURDA J

Price: 25.00

Research Provided by a Third Party

Company: HCA Healthcare, Inc.

Industry: Medical - Hospital

Record: 247

10/16/2014

Daily Note

Pages: 16

Morning Meeting Notes

Provider: KEYBANC CAPITAL MARKETS

Price: 50.00

Research Provided by a Third Party

Company: HCA Healthcare, Inc.

Industry: Medical - Hospital

Record: 248

10/15/2014

Company Report

Pages: 5

Pre-Announces Ahead on Stronger Volumes, Reform Benefits

Provider: KEYBANC CAPITAL MARKETS

Analyst: GURDA J

Price: 10.00

Research Provided by a Third Party

Company: HCA Healthcare, Inc.

Industry: Medical - Hospital

Record: 249

07/29/2014

Daily Note

Pages: 13

Research Summary

Provider: KEYBANC CAPITAL MARKETS

Price: 50.00

Research Provided by a Third Party

Company: HCA Healthcare, Inc.

Industry: Medical - Hospital

Record: 250

07/29/2014

Company Report

Pages: 8

Strong 2Q; In Line with Pre-Announcement

Provider: KEYBANC CAPITAL MARKETS

Analyst: GURDA J

Price: 25.00

Research Provided by a Third Party

Company: HCA Healthcare, Inc.

Industry: Medical - Hospital

Record: 251

07/16/2014

Company Report

Pages: 5

Pre-Announces Significantly Higher than Expected 2Q Results

Provider: KEYBANC CAPITAL MARKETS

Analyst: GURDA J

Price: 10.00

Research Provided by a Third Party

Company: HCA Healthcare, Inc.

Industry: Medical - Hospital

Record: 252

07/16/2014

Daily Note

Pages: 8

Research Summary

Provider: KEYBANC CAPITAL MARKETS

Price: 25.00

Research Provided by a Third Party

Company: HCA Healthcare, Inc.

Industry: Medical - Hospital

Record: 253

05/01/2014

Daily Note

Pages: 2

Proposed FY15 IPPS Rates Slightly Worse than Expected

Provider: KEYBANC CAPITAL MARKETS

Analyst: GURDA J

Price: 10.00

Research Provided by a Third Party

Company: HCA Healthcare, Inc.

Industry: Medical - Hospital

Record: 254

04/29/2014

Daily Note

Pages: 10

Research Summary

Provider: KEYBANC CAPITAL MARKETS

Price: 25.00

Research Provided by a Third Party

Company: HCA Healthcare, Inc.

Industry: Medical - Hospital

Record: 255

04/29/2014

Company Report

Pages: 9

Impact from Reform Is Modest, but Growing Rapidly

Provider: KEYBANC CAPITAL MARKETS

Analyst: GURDA J

Price: 25.00

Research Provided by a Third Party

Company: HCA Healthcare, Inc.

Industry: Medical - Hospital

Record: 256

04/29/2014

Daily Note

Pages: 3

Reform Impact Minimal w/1Q Slightly Below; Outlook Reaffirmed

Provider: KEYBANC CAPITAL MARKETS

Analyst: GURDA J

Price: 10.00

Research Provided by a Third Party

Company: HCA Healthcare, Inc.

Industry: Medical - Hospital

Record: 257

04/06/2014

Industry Report

Pages: 6

Healthcare Facilities: Recent Data Suggest Potential for Reform-Related Upside

Provider: KEYBANC CAPITAL MARKETS

Analyst: GURDA J

Price: 25.00

Research Provided by a Third Party

Company: HCA Healthcare, Inc.

Industry: Medical - Hospital

Record: 258

02/04/2014

Company Report

Pages: 8

Growth in Surgeries & Acuity Offsets Volume Softness

Provider: KEYBANC CAPITAL MARKETS

Analyst: GURDA J

Price: 25.00

Research Provided by a Third Party

Company: HCA Healthcare, Inc.

Industry: Medical - Hospital

Record: 259

02/04/2014

Daily Note

Pages: 3

4Q in Line with Pre-Announcement; 2014 Outlook Slightly Below Consensus

Provider: KEYBANC CAPITAL MARKETS

Analyst: GURDA J

Price: 10.00

Research Provided by a Third Party

Company: HCA Healthcare, Inc.

Industry: Medical - Hospital

Record: 260

01/14/2014

Daily Note

Pages: 16

Afternoon Call Summary

Provider: KEYBANC CAPITAL MARKETS

Price: 50.00

Research Provided by a Third Party